Accessibility Menu
 

FibroBiologics

(NASDAQ) FBLG

Current Price$1.34
Market Cap$4.78M
Since IPO (2024)-100%
5 YearN/A
1 Year-94%
1 Month-65%

FibroBiologics Financials at a Glance

Market Cap

$4.78M

Revenue (TTM)

$0.00

Net Income (TTM)

$18.65M

EPS (TTM)

$-8.78

P/E Ratio

-0.15

Dividend

$0.00

Beta (Volatility)

-0.13 (Low)

Price

$1.34

Volume

1,329

Open

$1.35

Previous Close

$1.34

Daily Range

$1.30 - $1.36

52-Week Range

$1.03 - $22.60

FBLG News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About FibroBiologics

Industry

Biotechnology

Employees

15

CEO

Peter O'Heeron

Headquarters

Houston, DE 77598, US

FBLG Financials

Key Financial Metrics (TTM)

Gross Margin

0%

Operating Margin

0%

Net Income Margin

0%

Return on Equity

-419%

Return on Capital

-2%

Return on Assets

-2%

Earnings Yield

-6.67%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$4.78M

Shares Outstanding

3.51M

Volume

1.33K

Avg. Volume

342.86K

Financials (TTM)

Gross Profit

$832.00K

Operating Income

$16.65M

EBITDA

$17.61M

Operating Cash Flow

$16.39M

Capital Expenditure

$262.00K

Free Cash Flow

$16.66M

Cash & ST Invst.

$4.89M

Total Debt

$2.41M

FibroBiologics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$0.00

N/A

Gross Profit

$234.00K

N/A

Gross Margin

0.00%

N/A

Market Cap

$4.78M

N/A

Market Cap/Employee

$367.50K

N/A

Employees

13

N/A

Net Income

$3.24M

-4.7%

EBITDA

$2.81M

+4.6%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$2.48M

-27.6%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$1.70M

+73.2%

Short Term Debt

$706.00K

-92.6%

Return on Assets

-1.94%

N/A

Return on Invested Capital

-2.12%

N/A

Free Cash Flow

$3.16M

+0.3%

Operating Cash Flow

$3.16M

-2.9%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
MBRXMoleculin Biotech, Inc.
$2.51-1.95%
CTXRCitius Pharmaceuticals, Inc.
$0.60-8.46%
AIMDAinos, Inc.
$1.72-4.44%
HOTHHoth Therapeutics, Inc.
$0.71-2.70%

Trending Stocks

Symbol / CompanyPricePrice Chg
INTCIntel
$94.75+0.12%
SOFISoFi Technologies
$15.53-0.15%
NOKNokia
$12.46+0.10%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$5.14+0.04%

Questions About FBLG

What is the current price of FibroBiologics?

FibroBiologics is trading at $1.34 per share.

What is the 52-week range for FibroBiologics?

Over the past 52 weeks, FibroBiologics has traded between $1.03 and $22.60.

How much debt does FibroBiologics have?

As of the most recent reporting period, FibroBiologics reported total debt of $2.41M.

How much cash does FibroBiologics have on hand?

FibroBiologics reported $4.89M in cash and cash equivalents in its most recent financial results.

What is FibroBiologics’s dividend yield?

FibroBiologics does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.